Manish Saxena
Overview
Explore the profile of Manish Saxena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
817
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamed T, Mckeown M, Saxena M
Cureus
. 2025 Mar;
17(2):e78348.
PMID: 40034634
The effectiveness of calorie restriction (CR) for weight loss in type 2 diabetes mellitus (T2DM) has not been thoroughly studied. This review aims to evaluate CR's short- and long-term effectiveness...
2.
Bloch M, Kirtane A, Azizi M, Mahfoud F, Basile J, Daemen J, et al.
Hypertens Res
. 2024 Sep;
47(12):3467-3472.
PMID: 39333663
Endovascular ultrasound renal denervation (uRDN) reduced blood pressure (BP) compared to sham at 2 months in patients with resistant hypertension in the multicenter, blinded, randomized, sham-controlled RADIANCE-HTN TRIO trial. This...
3.
Greene S, Bohm M, Bozkurt B, Butler J, Cleland J, Coats A, et al.
J Card Fail
. 2024 Sep;
PMID: 39277029
Background: Despite guideline recommendations, many patients with heart failure (HF) do not receive target dosages of renin-angiotensin-aldosterone system inhibitors (RAASis) in clinical practice due, in part, to concerns about hyperkalemia...
4.
Unverdorben M, Colonna P, Jin J, Kohler S, Santamaria A, Saxena M, et al.
Clin Appl Thromb Hemost
. 2024 Jun;
30:10760296241260728.
PMID: 38881370
NCT02950168, NCT02951039.
5.
6.
Hall C, Twelves J, Saxena M, Scapozza L, Gurry T
Br J Nutr
. 2024 Apr;
132(1):68-76.
PMID: 38654680
Prebiotic fibre represents a promising and efficacious treatment to manage pre-diabetes, acting via complementary pathways involving the gut microbiome and viscosity-related properties. In this study, we evaluated the effect of...
7.
Kandzari D, Weber M, Pathak A, Zidar J, Saxena M, David S, et al.
Circulation
. 2024 Apr;
149(24):1875-1884.
PMID: 38587557
Background: Renal denervation (RDN) has demonstrated clinically relevant reductions in blood pressure (BP) among individuals with uncontrolled hypertension despite lifestyle intervention and medications. The safety and effectiveness of alcohol-mediated RDN...
8.
Magavern E, Kapil V, Saxena M, Gupta A, Caulfield M
Arterioscler Thromb Vasc Biol
. 2024 Feb;
44(4):784-793.
PMID: 38385287
Hypertension is a prevalent public health problem, contributing to >10 million deaths annually. Though multiple therapeutics exist, many patients suffer from treatment-resistant hypertension or try several medications before achieving blood...
9.
Bakris G, Saxena M, Gupta A, Chalhoub F, Lee J, Stiglitz D, et al.
JAMA
. 2024 Feb;
331(9):740-749.
PMID: 38363577
Importance: Angiotensinogen is the most upstream precursor of the renin-angiotensin-aldosterone system, a key pathway in blood pressure (BP) regulation. Zilebesiran, an investigational RNA interference therapeutic, targets hepatic angiotensinogen synthesis. Objective:...
10.
Collier D, Taylor M, Godec T, Shiel J, James R, Chowdury Y, et al.
J Am Heart Assoc
. 2024 Feb;
13(4):e030749.
PMID: 38323513
Background: The objective of the PERSONAL-CovidBP (Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension: Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic) trial...